Elite Trades From Anywhere

$100 Off Your First Year

Claim Now
Last Close
222.21
Jun 30 • 01:32PM ET Dollar change+2.51 Percentage change(1.14%)
Index
S&P 500
Market Cap
14.27B
Enterprise Value
28.54B
Income
756.42M
Sales
13.84B
Book/sh
-11.41
Cash/sh
11.66
Employees
78000
IPO
Oct 31, 1995
P/E
21.33
Forward P/E
12.86
PEG
0.62
P/S
1.03
P/B
-
P/C
19.05
P/FCF
9.55
EV/EBITDA
10.31
EV/Sales
2.06
Quick Ratio
1.37
Current Ratio
1.42
Debt/Eq
-
LT Debt/Eq
-
Option/Short
Yes / Yes
EPS (ttm)
10.42
EPS next Y
17.28
EPS next Q
3.84
EPS this Y
37.72%
EPS next Y
16.38%
EPS next 5Y
20.68%
EPS past 3/5Y
18.56% 8.29%
Sales past 3/5Y
5.53% 3.39%
EPS Y/Y TTM
2.79%
Sales Y/Y TTM
6.68%
EPS Q/Q
43.08%
Sales Q/Q
5.96%
Insider Own
2.07%
Insider Trans
-69.67%
Inst Own
96.93%
Inst Trans
-4.05%
ROA
4.37%
ROE
635.30%
ROIC
6.35%
Gross Margin
27.27%
Oper. Margin
14.82%
Profit Margin
5.47%
SMA20
8.08%
SMA50
17.21%
SMA200
53.11%
Trades
Shs Outstand
66.19M
Shs Float
62.87M
52W High
221.59 0.28%
52W Low
101.00 120.00%
Volatility
2.41% 2.79%
ATR (14)
5.65
RSI (14)
78.15
Beta
0.87
Rel Volume
0.55
Avg Volume
851.40K
Volume
298,603
Perf Week
5.35%
Perf Month
14.33%
Perf Quarter
45.83%
Perf Half Y
94.95%
Perf YTD
95.59%
Perf Year
55.99%
Perf 3Y
121.17%
Perf 5Y
84.51%
Perf 10Y
187.38%
Prev Close
219.70
Price
222.21
Change
1.14%
Date Action Analyst Rating Change Price Target Change
May-06-26Upgrade Deutsche Bank Hold → Buy $220
Mar-06-24Initiated Barclays Equal Weight $133
Aug-07-23Upgrade UBS Neutral → Buy $100 → $142
Nov-01-22Downgrade Deutsche Bank Buy → Hold $97 → $72
Oct-31-22Downgrade UBS Buy → Neutral $117 → $74
Aug-19-22Resumed UBS Buy $106 → $117
Jun-21-22Reiterated BofA Securities Underperform $110 → $90
Sep-10-21Initiated Cowen Market Perform $145
Aug-12-21Downgrade Barclays Overweight → Equal Weight $135 → $146
Mar-26-21Downgrade BofA Securities Neutral → Underperform $127 → $118
May-18-26 03:00PM
May-12-26 10:41AM
May-06-26 06:01PM
May-05-26 04:05PM
Apr-20-26 02:06PM
08:06PM Loading…
Mar-31-26 08:06PM
Mar-18-26 03:00PM
Mar-06-26 11:49AM
Mar-05-26 12:40PM
Mar-04-26 11:30AM
10:08AM
Mar-03-26 06:56PM
Feb-27-26 04:48AM
04:03AM
03:50AM
02:00PM Loading…
Feb-24-26 02:00PM
09:40AM
02:53AM
Feb-23-26 09:40AM
Feb-20-26 09:50AM
04:09AM
Feb-19-26 09:20AM
05:30AM
04:34AM
Feb-17-26 04:53PM
Feb-13-26 10:24AM
Feb-12-26 11:03AM
10:54AM
10:41AM
09:25AM
09:15AM Loading…
Feb-11-26 09:15AM
Feb-10-26 12:30PM
09:32AM
Feb-09-26 10:38AM
08:50AM
12:31AM
Feb-05-26 09:40AM
09:40AM
Feb-04-26 07:55PM
02:54PM
10:59AM
Feb-03-26 06:03PM
04:26PM
01:18PM
12:38PM
12:25PM
11:45AM
11:16AM
11:14AM
10:23AM
09:59AM
09:40AM
08:10AM
05:54AM
12:01AM
Feb-02-26 09:55PM
08:40PM
06:38PM
05:20PM
04:20PM
04:05PM
03:00PM
Jan-31-26 10:01PM
Jan-30-26 11:56AM
Jan-29-26 11:34PM
Jan-27-26 06:00PM
Jan-21-26 06:15PM
10:00AM
Jan-19-26 12:31PM
Jan-16-26 01:56PM
04:25AM
Jan-15-26 10:34AM
Jan-14-26 11:50AM
Jan-13-26 06:00PM
Jan-07-26 06:00PM
06:00AM
Jan-02-26 09:32AM
Dec-29-25 08:53AM
01:30AM
Dec-23-25 09:02AM
Dec-22-25 06:00PM
09:14AM
Dec-19-25 09:13AM
Dec-18-25 09:07AM
Dec-15-25 09:05AM
Dec-11-25 08:00AM
Nov-28-25 11:30AM
Nov-24-25 11:49AM
Nov-14-25 04:53PM
04:16PM
Nov-13-25 10:31PM
Nov-12-25 01:11PM
Nov-10-25 06:41AM
Nov-05-25 12:38AM
Nov-04-25 08:00AM
Nov-02-25 01:07PM
Oct-30-25 07:39PM
01:59PM
01:35AM
Oct-29-25 05:25PM
DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
CEO & Executive DirectorMr. Javier J. Rodriguez
CFO & TreasurerMr. Joel Ackerman
Chief Legal & Public Affairs OfficerMs. Kathleen Alyce Waters
Chief Compliance OfficerMr. James O. Hearty
Chief Operating Officer of DaVita Kidney CareMr. David P. Maughan
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Waters Kathleen AlyceChief Legal & Pub. Affairs OffJun 15 '26Sale208.4015,4053,210,377109,194Jun 17 06:10 PM
Rodriguez JavierChief Executive OfficerJun 16 '26Sale209.2839,4078,247,018840,408Jun 17 06:09 PM
Rodriguez JavierChief Executive OfficerJun 15 '26Sale209.5030,0006,285,090879,815Jun 17 06:09 PM
Javier RodgriguezOfficerJun 16 '26Proposed Sale209.2839,4078,247,016Jun 16 04:44 PM
Kathleen WatersOfficerJun 15 '26Proposed Sale207.848,9501,860,202Jun 15 04:53 PM
Javier RodriguezOfficerJun 15 '26Proposed Sale209.5030,0006,285,102Jun 15 04:48 PM
Waters Kathleen AlyceOfficerJun 15 '26Proposed Sale207.936,4551,342,188Jun 15 04:10 PM
HEARTY JAMES OChief Compliance OfficerMay 14 '26Option Exercise110.635,784639,88441,737May 18 04:08 PM
HEARTY JAMES OChief Compliance OfficerMay 15 '26Sale193.9815,0002,909,74522,389May 18 04:08 PM
James HeartyOfficerMay 15 '26Proposed Sale193.9315,0002,908,950May 15 03:12 PM
Maughan David PaulChief Operating Officer, DKCMay 12 '26Sale199.2513,4562,681,16294,105May 13 04:10 PM
Maughan David PaulChief Operating Officer, DKCMay 11 '26Sale199.157,0731,408,581107,561May 13 04:10 PM
David MaughanOfficerMay 11 '26Proposed Sale198.0320,5294,065,340May 11 05:40 PM
ACKERMAN JOELCFO and TreasurerMay 07 '26Sale192.1051,4719,887,528132,434May 11 04:05 PM
HEARTY JAMES OChief Compliance OfficerMay 06 '26Sale174.872,184381,91635,953May 08 04:04 PM
Joel AckermanOfficerMay 07 '26Proposed Sale191.5051,4719,856,696May 07 04:43 PM
HEARTY JAMES OOfficerMay 06 '26Proposed Sale169.282,184369,708May 06 04:03 PM
BERKSHIRE HATHAWAY INC10% OwnerMay 01 '26Sale149.841,220,376182,864,67928,880,209May 05 06:52 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffFeb 06 '26Option Exercise108.938,079880,045105,833Feb 09 06:57 PM
ACKERMAN JOELCFO and TreasuerFeb 06 '26Option Exercise108.9344,0654,800,000185,705Feb 09 06:56 PM
BERKSHIRE HATHAWAY INC10% OwnerJan 29 '26Sale120.561,658,480199,939,88130,100,585Feb 02 05:30 PM
HEARTY JAMES OChief Compliance OfficerDec 04 '25Option Exercise108.935,875639,96431,913Dec 05 04:35 PM
BERKSHIRE HATHAWAY INC10% OwnerOct 27 '25Sale135.36401,51454,347,24931,759,065Oct 29 06:09 PM
BERKSHIRE HATHAWAY INC10% OwnerJul 31 '25Sale140.611,635,962230,024,76432,160,579Aug 04 09:00 PM
HEARTY JAMES OChief Compliance OfficerJul 23 '25Sale150.002,351352,65026,038Jul 24 08:34 PM
HEARTY JAMES OOfficerJul 23 '25Proposed Sale150.002,351352,650Jul 23 04:05 PM